Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Condition(s):Small Intestine Adenocarcinoma; Recurrent Small Intestine CancerLast Updated:August 24, 2017Completed